Study offers significant benefits to cancer patients for 18 months after a…
Positive long-term follow-up data from Sunstone Therapies’ investigator-initiated Phase 2 study evaluating COMPASS Pathways CMPS synthetic psilocybin COMP360 coupled with psychological support for cancer patients